# Molecular Evaluation in Metastatic Breast Cancer

> **NCT03358589** · NA · UNKNOWN · sponsor: **Odense University Hospital** · enrollment: 270 (estimated)

## Conditions studied

- Metastatic Breast Cancer
- Molecular Imaging

## Interventions

- **DIAGNOSTIC_TEST:** FDG-PET/CT

## Key facts

- **NCT ID:** NCT03358589
- **Lead sponsor:** Odense University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-09-01
- **Primary completion:** 2019-08-31
- **Final completion:** 2021-08-31
- **Target enrollment:** 270 (ESTIMATED)
- **Last updated:** 2021-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03358589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03358589, "Molecular Evaluation in Metastatic Breast Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03358589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*